← Back to headlines
Neurocrine Biosciences Presents Two-Year Data from CAHtalyst® Adult Study
Neurocrine Biosciences announced the first presentation of new two-year data from its Phase 3 CAHtalyst® Adult Study. This data provides further insights into the efficacy and safety of their treatment.
1 May, 07:57 — 1 May, 07:57
Sources
Showing 1 of 1 sources
